A 3-year-old girl is one of the first children in the United States to receive both shots of Pfizer’s coronavirus vaccine in a study testing the safety and effectiveness of the doses on young children.
“We talk a lot about how she’s been very brave to participate in the trial. And the vaccine is something that will help her body be strong to fight against the virus,” Angelica Lacour, the mother of 3-year-old Eloise Lacour, said of the trial.
“Whatever we can do to protect her, even though chances are she’d be totally fine if she caught the virus, we don’t know what the long-term effects are,” her mother added.
Eloise is among the first children in the country under the age of 5 to receive both doses amid a study led by Dr. Yvonne Maldonado at the Stanford University School of Medicine. Health officials are working to figure out “what doses are the lowest doses that produce the best immune response with the least side effects” for younger children, Maldonado said, and she hopes to enroll thousands of children in the research.
BIDEN ADMINISTRATION LAUNCHES $350 BILLION COVID-19 PAYMENTS FOR STATE AND LOCAL GOVERNMENTS
Eloise receiving the second dose comes amid reports that the Food and Drug Administration is expected to soon approve the Pfizer vaccine for children aged 12-15.
A recent survey, however, showed that less than a third of parents plan to get their children vaccinated immediately, with some citing that they want to see how the vaccine works before their children are inoculated.
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
The Centers for Disease Control and Prevention also stated that though children can get infected by the coronavirus, “most children with COVID-19 have mild symptoms or have no symptoms at all.”
